In the same year, Boulet et al. [40] reported that in patients with mild allergic asthma, the anti-IgE mAb rhuMAb-E25 administered at 1.0 mg/kg during six visits slightly, although significantly (p < 0.05), improved methacholine PC20. The gene discussed is IGHE; the disease is allergic asthma.